Haoxi Health Technology (NASDAQ:HAO) Lowered to Sell Rating by Wall Street Zen

Wall Street Zen downgraded shares of Haoxi Health Technology (NASDAQ:HAO) from a hold rating to a sell rating in a report published on Sunday morning.

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Haoxi Health Technology in a report on Friday, July 17th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Haoxi Health Technology currently has a consensus rating of “Sell”.

Haoxi Health Technology Price Performance

Shares of HAO stock opened at $3.27 on Friday. The stock has a fifty day moving average price of $10.58 and a 200 day moving average price of $1,352.50. Haoxi Health Technology has a 1 year low of $2.70 and a 1 year high of $5,708.80.

Haoxi Health Technology Company Profile

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.